NCM
Northroad Capital Management Portfolio holdings
AUM
$43.8M
Turnover
28.3%
1-Year Est. Return
1.99%
This Fund
S&P 500
This Quarter
Est. Return
-1.39%
1 Year Est. Return
+1.99%
3 Year Est. Return
+0.16%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$258M
AUM Growth
–
Cap. Flow
+$265M
Cap. Flow
% of AUM
102.68%
Top 10 Holdings %
Top 10 Hldgs %
32.86%
Holding
56
New
56
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$12.3M |
| 2 |
Sanofi
SNY
|
+$8.8M |
| 3 |
GSK
GSK
|
+$8.53M |
| 4 |
HSBC
HSBC
|
+$7.63M |
| 5 |
Mitsubishi UFJ Financial
MUFG
|
+$7.6M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.93% |
| 2 | Healthcare | 14.02% |
| 3 | Financials | 12.94% |
| 4 | Technology | 11.34% |
| 5 | Energy | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Novartis
NVS
$279B
| $12M | 4.65% |
+189,106
| New | +$12.3M |
2013 Q2
0 quarters
|
|
|
2
Sanofi
SNY
$95.3B
| $8.51M | 3.3% |
+165,228
| New | +$8.8M |
2013 Q2
0 quarters
|
|
|
3
GSK
GSK
$96B
| $8.39M | 3.26% |
+134,385
| New | +$8.53M |
2013 Q2
0 quarters
|
|
4
TotalEnergies
TTE
$198B
| $7.49M | 2.91% |
+153,869
| New | +$7.6M |
2013 Q2
0 quarters
|
|
|
5
Mitsubishi UFJ Financial
MUFG
$246B
| $7.37M | 2.86% |
+1,186,889
| New | +$7.6M |
2013 Q2
0 quarters
|
|
|
6
HSBC
HSBC
$321B
| $7.29M | 2.83% |
+163,106
| New | +$7.63M |
2013 Q2
0 quarters
|
|
|
RDS.A
7
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $7.24M | 2.81% |
+121,405
| New | +$7.51M |
2013 Q2
0 quarters
|
|
8
Diageo
DEO
$51.1B
| $6.9M | 2.68% |
+60,061
| New | +$7.26M |
2013 Q2
0 quarters
|
|
|
SYT
9
DELISTED
Syngenta Ag
SYT
| $6.81M | 2.64% |
+87,507
| New | +$7.09M |
2013 Q2
0 quarters
|
|
10
SAP
SAP
$254B
| $6.79M | 2.63% |
+93,209
| New | +$7.25M |
2013 Q2
0 quarters
|
|
11
WPP
WPP
$5.49B
| $6.52M | 2.53% |
+76,334
| New | +$6.44M |
2013 Q2
0 quarters
|
|
12
Unilever
UL
$137B
| $6.36M | 2.47% |
+139,723
| New | +$6.64M |
2013 Q2
0 quarters
|
|
13
ENI
E
$82.8B
| $6.21M | 2.41% |
+151,388
| New | +$6.94M |
2013 Q2
0 quarters
|
|
|
ITY
14
DELISTED
IMPERIAL TOBACCO GRP ADS(RP 2
ITY
| $6.16M | 2.39% |
+88,380
| New | +$6.16M |
2013 Q2
0 quarters
|
|
15
Vodafone
VOD
$35.9B
| $5.99M | 2.32% |
+204,348
| New | +$6.1M |
2013 Q2
0 quarters
|
|
|
ABB
16
DELISTED
ABB Ltd
ABB
| $5.94M | 2.3% |
+274,174
| New | +$6.07M |
2013 Q2
0 quarters
|
|
17
RELX
RELX
$64B
| $5.9M | 2.29% |
+517,580
| New | +$5.99M |
2013 Q2
0 quarters
|
|
|
AXA
18
DELISTED
AXA ADS (1 ORD SHS)
AXA
| $5.78M | 2.24% |
+293,418
| New | +$5.78M |
2013 Q2
0 quarters
|
|
19
Ericsson
ERIC
$31B
| $5.71M | 2.22% |
+506,657
| New | +$6.06M |
2013 Q2
0 quarters
|
|
20
CRH
CRH
$52.8B
| $5.7M | 2.21% |
+280,848
| New | +$5.93M |
2013 Q2
0 quarters
|
|
21
Baidu
BIDU
$27.8B
| $5.66M | 2.2% |
+59,845
| New | +$5.51M |
2013 Q2
0 quarters
|
|
|
AKZOY
22
DELISTED
Akzo Nobel NV
AKZOY
| $5.62M | 2.18% |
+298,982
| New | +$5.62M |
2013 Q2
0 quarters
|
|
23
DELISTED
Allianz Se Sponsored Adr Repstg 1/10 Ord Sh
AZ
| $5.33M | 2.07% |
+364,968
| New | +$5.33M |
2013 Q2
0 quarters
|
|
|
CAJ
24
DELISTED
Canon, Inc.
CAJ
| $5.22M | 2.03% |
+158,893
| New | +$5.61M |
2013 Q2
0 quarters
|
|
25
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
| $5.07M | 1.97% |
+129,321
| New | +$5.04M |
2013 Q2
0 quarters
|
|
Similar funds
CC
RAM
ACI
QCM
NHG
RVGI
BS
BSCM
Northroad Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Northroad Capital Management, which disclosed 56 positions worth $258M. Its ten largest holdings account for 33% of the portfolio.
Its largest position is Novartis: 189,106 shares worth $12M.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, followed by Healthcare and Financials.
- Northroad Capital Management's largest Q2 2013 buy was Novartis: 189,106 shares worth $12M.
- Northroad Capital Management's ten largest holdings make up 33% of its $258M portfolio in Q2 2013.
- Northroad Capital Management disclosed 56 positions in Q2 2013, its first 13F filing on record.
Based on Northroad Capital Management's 13F filing for Q2 2013, filed 31 Jul 2013.